Erik Huneker
Overview
Explore the profile of Erik Huneker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beolet T, Adenis A, Huneker E, Louis M
Artif Intell Med
. 2024 Jul;
154:102920.
PMID: 38972092
The development of closed-loop systems for glycemia control in type I diabetes relies heavily on simulated patients. Improving the performances and adaptability of these close-loops raises the risk of over-fitting...
2.
Kariyawasam D, Morin C, Casteels K, Le Tallec C, Sfez A, Godot C, et al.
Lancet Digit Health
. 2022 Feb;
4(3):e158-e168.
PMID: 35216750
Background: Time in range (TIR) goals are rarely met in children with type 1 diabetes, except at the cost of increased hypoglycaemia episodes. Our objective was to evaluate the safety...
3.
Amadou C, Franc S, Huneker E, Charpentier G, Penfornis A
Diabetes Metab
. 2021 Oct;
48(4):101294.
PMID: 34666166
No abstract (brief report).
4.
Lachal S, Tourki Y, Franc S, Huneker E, Charpentier G, Benhamou P
J Diabetes Sci Technol
. 2021 Oct;
17(1):176-185.
PMID: 34658265
Objective: There is room for improvement in the performance of closed-loop regulation algorithms during the prandial period. This in silico study evaluated the efficiency and safety of ultrarapid lispro insulin...
5.
Delageniere J, Schwartz C, Doron M, Huneker E, Franc S, Charpentier G, et al.
Acta Diabetol
. 2021 Jul;
58(12):1709-1711.
PMID: 34272606
No abstract available.
6.
Franc S, Benhamou P, Borot S, Chaillous L, Delemer B, Doron M, et al.
Diabetes Obes Metab
. 2021 May;
23(9):2170-2176.
PMID: 34009725
A post hoc analysis of the Diabeloop WP7 multicentre, randomized controlled trial was performed to investigate the efficacy of the Diabeloop Generation-1 (DBLG1) closed-loop system in controlling the hypoglycaemia induced...
7.
Amadou C, Franc S, Benhamou P, Lablanche S, Huneker E, Charpentier G, et al.
Diabetes Care
. 2021 Jan;
44(3):844-846.
PMID: 33431420
Objective: To analyze safety and efficacy of the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system in patients with type 1 diabetes in real-world conditions. Research Design And Methods:...
8.
Villeneuve E, Lachal S, Desir C, Benhamou P, Franc S, Charpentier G, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2020 Oct;
2020:5093-5096.
PMID: 33019132
The daily challenge for people with type 1 diabetes is maintaining glycaemia in the "normal" range after meals, by injecting themselves the correct amount of insulin. Artificial pancreas systems were...
9.
Hanaire H, Franc S, Borot S, Penfornis A, Benhamou P, Schaepelynck P, et al.
Diabetes Obes Metab
. 2019 Oct;
22(3):324-334.
PMID: 31621186
Aims: To compare closed-loop (CL) and open-loop (OL) systems for glycaemic control in patients with type 1 diabetes (T1D) exposed to real-life challenging situations (gastronomic dinners or sustained physical exercise)....
10.
Benhamou P, Huneker E, Franc S, Doron M, Charpentier G
Acta Diabetol
. 2018 Mar;
55(6):549-556.
PMID: 29520615
Aims: Improvement in closed-loop insulin delivery systems could result from customization of settings to individual needs and remote monitoring. This pilot home study evaluated the efficacy and relevance of this...